NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Lite Strategy, Inc. Common Stock (LITS)

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Ticker
LITS
Exchange
XNAS
Sector
Healthcare
Industry
Biotechnology

Company profile updated October 12, 2026.

Stored market snapshot

As of October 9, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$1.27
Company market capitalization (USD)
$38,617,230.36
Price / book
0.93×

Research LITS

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: